期刊文献+

双氢青蒿素抑制肝癌细胞生长机制的初步研究

Preliminary Study on Mechanism of Dihydroartemisinin Inhibiting Proliferation of Hepatocellular Carcinoma Cells
下载PDF
导出
摘要 目的初步探究双氢青蒿素对肝癌细胞Huh7和Huh6生长的影响及可能存在的机制。方法培养肝癌细胞Huh7和Huh6,使用CCK-8法和结晶紫染色检测双氢青蒿素对肝癌细胞Huh7和Huh6生长抑制情况。Western Blot检测药物作用于细胞48 h后,AKT/mTOR信号通路相关蛋白的表达水平。结果与对照组相比,双氢青蒿素(12.5μM、25μM、50μM)可以下调AKT/mTOR信号通路p-AKT、p-S6K、p-S6蛋白的表达水平,从而影响肝癌细胞的生长。结论双氢青蒿素通过抑制AKT/mTOR信号通路从而抑制肝癌细胞生长。 Objective To study inhibiting effect of dihydroartemisinin(DHA)on proliferation of hepatocellular carcinoma cells and preliminary explore the mechanism.Methods Huh7 and Huh6 cells were cultured.The viability of the cells was detected with CCK-8 assay and colony forming assay.The effect of DHA on Huh7 and Huh6 migration of hepatocellular carcinoma cells was observed by using cell scratch test.We observed the changes of AKT/mTOR signaling pathway related proteins expressions with Western Blot.Results DHA(12.5μM,25μM,50μM)could significantly inhibit the proliferation of hepatocellular carcinoma cells at 48 hours.Western blot showed that compared with the control group,the DHA group could down-regulate the expressions of AKT/mTOR signaling pathway related proteins,such as p-AKT,p-S6K and p-S6,thereby affecting the growth of liver cancer cells.Conclusion DHA inhibits the growth of hepatocellular carcinoma cells by inhibiting AKT/mTOR signaling pathway.
作者 王惠国 李丹 杨加顺 毛筝 李雨桐 张静莹 孙颖超 唐玲 WANG Huiguo;LI Dan;YANG Jiashun;MAO Zheng;LI Yutong;ZHANG Jingying;SUN Yingchao;TANG Ling(College of Life Science and Technology,Dalian University,Dalian 116622,Liaoning,China;The Third Affiliated Hospital of Southern Medical Universiy,Guangzhou 510630 Guangdong,China;The Second Clinical Medical College of Guangdong Medical University,Dongguan 523808,Guangdong,China;Dalian Sanyi Animal Medicine Company,Dalian 116036,Liaoning,Ghina;College of Traditional Chinese Medicine,Southern Medical University,Guangzhou 510515,Guangdong,Chian)
出处 《辽宁中医杂志》 CAS 2020年第4期153-156,I0001,共5页 Liaoning Journal of Traditional Chinese Medicine
基金 国家自然科学基金面上项目(81573661) 广东医科大学帮扶专项资金项目(4SG19044G,4SG19057G)。
关键词 双氢青蒿素(DHA) 肝癌 AKT/MTOR P-AKT p-S6K p-S6 dihydroartemisinin hepatocellular carcinoma AKT/mTOR p-AKT p-S6K p-S6
  • 相关文献

参考文献1

二级参考文献189

  • 1Jian-Yong Lei,Wen-Tao Wang,Lu-Nan Yan.“Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma:A single-center analysis in China's Mainland[J].World Journal of Gastroenterology,2013,19(44):8093-8098. 被引量:5
  • 2F. Y.Yao,L.Xiao,N. M.Bass,R.Kerlan,N. L.Ascher,J. P.Roberts.Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging[J].American Journal of Transplantation.2007(11)
  • 3Pierre-Alain Clavien,Mickael Lesurtel,Patrick MM Bossuyt,Gregory J Gores,Bernard Langer,Arnaud Perrier.Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report[J]. Lancet Oncology . 2012 (1)
  • 4Josep M. Llovet,Jordi Bruix.Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J]. Hepatology . 2003 (2)
  • 5Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncology.2009(1)
  • 6European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].Journal of Hepatology.2012(4)
  • 7Riccardo Lencioni,Josep Llovet.Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma[J].Semin Liver Dis.2010(01)
  • 8F.Xavier Bosch,Josepa Ribes,Mireia Díaz,Ramon Cléries.Primary liver cancer: Worldwide incidence and trends[J].Gastroenterology.2004(5)
  • 9Francesca Bravi,Cristina Bosetti,Alessandra Tavani,Silvano Gallus,Carlo La Vecchia.Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-Analysis[J].Clinical Gastroenterology and Hepatology.2013
  • 10E. Terzi,R. Golfieri,F. Piscaglia,M. Galassi,A. Dazzi,S. Leoni,E. Giampalma,M. Renzulli,L. Bolondi.Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”[J].Journal of Hepatology.2012(6)

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部